Of the 42 responders, 26.7% (P=0.0003) discontinued treatment due to unsatisfactory pain relief or adverse effects. 71.8% of the responders had pain …
Source: pain relief
According to research results published in Pain Medicine, intravenous (IV) ketamine … neuropathic pain (CNP) in patients with refractory pain control.
Source: nerve pain medication
In individuals with knee osteoarthritis (OA) who are ineligible for knee … analog scale (VAS) knee pain at week 12, with a larger pain reduction in the …
Source: knee pain relief
Numerous treatment options are currently available for the treatment of PsA, including nonsteroidal anti-inflammatory drugs, conventional …
Source: joint pain medication